Kathleen A. Rickard, Chief Medical Officer at Verona Pharma plc (VRNA), sold 172,520 shares at $0.59 ($99K) on 2022-04-08, disclosed to the SEC on 2022-04-12.
Open-market sale of $99k VRNA by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.59 | 112,800 | $67K | 67.4% |
| 2 | $0.54 | 59,720 | $32K | 32.6% |
| Total | $0.57 avg | 172,520 | $99K | 100% |
| Filing → |
| VRNA | SELL | 2025-05-05 | $881K | — | Filing → |
| VRNA | SELL | 2025-05-01 | $618K | — | Filing → |
| VRNA | SELL | 2025-03-13 | $1.3M | — | Filing → |